文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征分子表型具有不同的下呼吸道转录组

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01
一句话结论高炎症型与低炎症型ARDS的呼吸道转录组不同,高炎症型以肺部干扰素刺激基因表达增加和T细胞活化为特征。

本研究比较了高炎症型与低炎症型ARDS患者的气管抽吸物基因表达,包括COVID-19和非COVID-19 ARDS的bulk RNA测序以及非COVID-19 ARDS的单细胞RNA测序,并在部分受试者中比较了血浆蛋白质组数据。在非COVID-19 ARDS中,1,157个基因在表型间差异表达(错误发现率<0.1);在COVID-19 ARDS中,85个基因差异表达。两个队列中可重复差异表达的基因有18个,包括高炎症型ARDS中IL32、HSPA8和PPP3CC表达更高。基因集富集分析显示195条通路在两个队列中可重复富集,包括高炎症型ARDS中粒细胞生成、T细胞和IFN信号以及整合应激反应通路表达更高。单细胞RNA测序网络分析显示高炎症型ARDS中T细胞向其他免疫细胞的信号更强。结论:高炎症型和低炎症型ARDS分子表型具有不同的呼吸道生物学特征,高炎症型ARDS以肺部干扰素刺激基因表达增加和T细胞活化为特征。

要点

  • 高炎症型与低炎症型ARDS可通过血浆生物标志物分型,两型临床轨迹和治疗反应不同。
  • 非COVID-19 ARDS中1,157个基因、COVID-19 ARDS中85个基因在两表型间差异表达(错误发现率<0.1)。
  • 18个基因在两个队列中可重复差异表达,高炎症型ARDS中IL32、HSPA8、PPP3CC表达更高。
  • 195条通路可重复富集,高炎症型ARDS中粒细胞生成、T细胞和IFN信号、整合应激反应通路表达更高。
  • 单细胞RNA测序显示高炎症型ARDS中T细胞向其他免疫细胞的信号更强。

适用人群与场景

  • 研究纳入COVID-19 ARDS和非COVID-19 ARDS患者,采集气管抽吸物进行RNA测序,部分受试者采集血浆蛋白质组数据。

研究设计与关键结果

  • 研究类型为观察性比较研究,比较高炎症型与低炎症型ARDS患者的气管抽吸物基因表达。
  • 非COVID-19 ARDS bulk RNA测序中,1,157个基因在两表型间差异表达(错误发现率<0.1)。
  • COVID-19 ARDS bulk RNA测序中,85个基因在两表型间差异表达。
  • 两个队列中18个基因可重复差异表达,高炎症型ARDS中IL32、HSPA8和PPP3CC表达更高。
  • 基因集富集分析显示195条通路在两个队列中可重复富集,高炎症型ARDS中粒细胞生成、T细胞和IFN信号以及整合应激反应通路表达更高。
  • 第三个患者组的单细胞RNA测序网络分析显示,高炎症型ARDS中T细胞向其他免疫细胞的信号更强。
  • 在部分受试者中比较了血浆蛋白质组数据。

证据类型、等级与局限

  • 证据类型为观察性比较研究,使用bulk RNA测序和单细胞RNA测序。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Two molecular phenotypes of the acute respiratory distress syndrome (ARDS) with divergent clinical trajectories and responses to therapy have been identified. Classification as "hyperinflammatory" or "hypoinflammatory" depends on plasma biomarker profiling. Limited data are available about the differences in the pulmonary biology of the molecular phenotypes. Objectives: To identify differences in the pulmonary biology of ARDS molecular phenotypes Methods: We compared tracheal aspirate gene expression between hyperinflammatory and hypoinflammatory phenotypes in bulk RNA sequencing (RNASeq) from coronavirus disease (COVID-19) and non-COVID-19 ARDS and single-cell RNASeq from non-COVID-19 ARDS. In a subset of subjects, we also compared plasma proteomic data. Measurements and Main Results: In bulk RNASeq analyses, 1,157 genes were differentially expressed (false discovery rate < 0.1) between phenotypes in non-COVID-19 ARDS, and 85 genes were differentially expressed between phenotypes in COVID-19 ARDS. Eighteen genes were reproducibly differentially expressed between phenotypes in both cohorts, including greater expression of IL32, HSPA8, and PPP3CC in hyperinflammatory ARDS. A total of 195 pathways were reproducibly enriched across the two cohorts by gene set enrichment analysis, including greater expression of granulopoiesis, T-cell and IFN signaling, and integrated stress response pathways in hyperinflammatory ARDS. Network analysis of single-cell RNASeq in a third group of patients identified greater T-cell signaling to other immune cells in hyperinflammatory ARDS. Conclusions: Hyperinflammatory and hypoinflammatory ARDS molecular phenotypes have distinct respiratory biology. Hyperinflammatory ARDS is characterized by an increased IFN-stimulated gene expression and T-cell activation in the lungs.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sarma A, Christenson SA, Shoshana BZ, et al. Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes. Am J Respir Crit Care Med. 2025. PMID: 40997225. doi:10.1164/rccm.202407-1454OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。